Kaos Capital Proposes Board Changes at Capricor Therapeutics

Kaos Capital has initiated steps to propose changes to the board at Capricor Therapeutics. This move is part of a broader effort to influence the company's strategic direction. While no specific figures or quantitative data were mentioned, the push for board changes signals a potential shift in governance that could affect shareholder interests. For investors, this could lead to changes in the company's operational decisions and overall market performance.